Wyeth Low-Dose PremPro Osteoporosis sNDA Filing Planned For June
Wyeth-Ayerst will file a low-dose PremPro sNDA for osteoporosis by the end of June, North American President Joseph Mahady said during American Home Products' May 16 analyst meeting in New York City.